Literature DB >> 15922142

Contributions of observational cohort studies in systemic lupus erythematosus: the university of toronto lupus clinic experience.

Murray B Urowitz1, Dafna D Gladman.   

Abstract

This article uses the University of Toronto Lupus Cohort to illustrate the benefits of observational cohort studies in generating important new knowledge in chronic disease such as systemic lupus erythematosus.

Entities:  

Mesh：

Year:  2005        PMID： 15922142     DOI： 10.1016/j.rdc.2005.01.008

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN： 0889-857X            Impact factor:   2.670


  9 in total

Review 1.  The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus.

Authors:  Ozan Ünlü; Stephane Zuily; Doruk Erkan
Journal:  Eur J Rheumatol       Date:  2015-12-29

2.  Indian SLE Inception cohort for Research (INSPIRE): the design of a multi-institutional cohort.

Authors:  Vineeta Shobha; Amita Aggarwal; Liza Rajasekhar; Avinash Jain; Ranjan Gupta; Bidyut Das; Ashish J Mathew; Manish Rathi; Parasar Ghosh; Vir Singh Negi; Abhishek Tripathi; Ramnath Misra
Journal:  Rheumatol Int       Date:  2021-01-12       Impact factor: 2.631

3.  Comparison of systemic lupus erythematosus (SLE) patients managed early after diagnosis in specialty versus community care clinics.

Authors:  Roaa Aljohani; Dafna D Gladman; Jiandong Su; Murray B Urowitz
Journal:  Clin Rheumatol       Date:  2017-06-06       Impact factor: 2.980

4.  National systemic lupus erythematosus prospective cohort in Saudi Arabia: A study protocol.

Authors:  Ibrahim A Almaghlouth; Lena M Hassen; Hana S Alahmari; Asma Bedaiwi; Rana Albarrak; Maha Daghestani; Eman Alqurtas; Abdulaziz Alkhalaf; Mohammed Bedaiwi; Mohammed Omair; Sultan Almogairen; Hussein Alarfaj; Abdulrahman Alarfaj
Journal:  Medicine (Baltimore)       Date:  2021-07-30       Impact factor: 1.817

5.  The Canadian Glomerulonephritis Registry (CGNR) and Translational Research Initiative: Rationale and Clinical Research Protocol.

Authors:  Ainslie M Hildebrand; Moumita Barua; Sean J Barbour; Karthik K Tennankore; Daniel C Cattran; Tomoko Takano; Ping Lam; Sacha A De Serres; Ratna Samanta; Michelle A Hladunewich; Todd Fairhead; Penelope Poyah; D Danielle Bush; Brian MacLaren; Dwight Sparkes; Philip Boll; Arenn Jauhal; Rohan John; Carmen Avila-Casado; Heather N Reich
Journal:  Can J Kidney Health Dis       Date:  2022-04-08

6.  Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus.

Authors:  Jagan Sivakumaran; Paula Harvey; Ahmed Omar; Oshrat Tayer-Shifman; Murray B Urowitz; Dafna D Gladman; Nicole Anderson; Jiandong Su; Zahi Touma
Journal:  Lupus Sci Med       Date:  2021-05

Review 7.  Lupus Cohorts.

Authors:  Christopher Redmond; Omer Pamuk; Sarfaraz A Hasni
Journal:  Rheum Dis Clin North Am       Date:  2021-06-10       Impact factor: 2.032

8.  Slicc damage index score in systemic lupus erythematosus patients and its associated factors.

Authors:  Wan Syamimee Wan Ghazali; Saidatul Manera Mohd Daud; Nurashikin Mohammad; Kah Keng Wong
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

9.  The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus.

Authors:  Alessandra Bortoluzzi; Cecilia Beatrice Chighizola; Micaela Fredi; Elena Raschi; Caterina Bodio; Daniela Privitera; Arianna Gonelli; Ettore Silvagni; Marcello Govoni; Ilaria Cavazzana; Paolo Airò; Pier Luigi Meroni; Angela Tincani; Franco Franceschini; Silvia Piantoni; Fabio Casciano
Journal:  Front Immunol       Date:  2020-10-29       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.